Breaking News Instant updates and real-time market news.

CCL

Carnival

$65.92

2.4185 (3.81%)

, AAPL

Apple

$150.55

-1.34 (-0.88%)

10:18
09/26/17
09/26
10:18
09/26/17
10:18

Carnival to launch digital streaming channel Ocean View

Continues to project cash flow in 2017 of $5B. Plans to launch own digital streaming channel, Ocean View to accelerate and expand engagement. Launching with two new original series on Apple (AAPL) TV, Amazon (AMZN) Fire, Roku. Will launch new gaming platform, Play Ocean, for mobile gaming. Continues to focus on managing costs. Says 'well-positioned' heading into 2018. Says already ahead in price and occupancy. Comments taken from Q3 conference call.

CCL

Carnival

$65.92

2.4185 (3.81%)

AAPL

Apple

$150.55

-1.34 (-0.88%)

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

  • 26

    Sep

  • 03

    Oct

  • 22

    Oct

CCL Carnival
$65.92

2.4185 (3.81%)

09/25/17
SUSQ
09/25/17
NO CHANGE
Target $76
SUSQ
Positive
Carnival estimates raised at Susquehanna despite hurricane disruption
Susquehanna analyst Rachael Rothman raised her estimates and price target on Carnival despite the recent hurricane disruptions. She sees the recent pullback in the shares as a buying opportunity and sees no change to the long-term demand environment. Rothman, who also sees the quality of management's decisions as sound, raised her price target to $76 from $75 on Carnival shares.
09/15/17
09/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Equifax (EFX) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg citing news of a major hack on the company's data that could have lasting effects. 2. FedEx (FDX) downgraded to Neutral from Buy at UBS with analyst Thomas Wadewitz citing TNT issues following the cyber-attack in June that knocked out multiple systems. 3. Carnival (CCL) downgraded to Neutral from Outperform at Credit Suisse with analyst Tim Ramskil saying he is worried that his estimate of absolute industry capacity growth in 2018-2021 is double that of the last five years. 4. American Airlines (AAL), United Continental (UAL), and Spirit Airlines (SAVE) were downgraded to Neutral from Overweight at JPMorgan. 5. Acuity Brands (AYI) downgraded to Market Perform from Outperform at Wells Fargo with analyst Richard Kwas saying his firm's electrical channel checks indicate the 8% consensus organic revenue growth estimate for FY18 does not have upside. The analyst thinks shares are likely range-bound in the $160-$200 range "for the time being." He believes a "material step up" in tiered solutions growth is needed for gross margin to outperform expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/15/17
09/15/17
DOWNGRADE
Target $70

Neutral
Carnival downgraded to Neutral on capacity concerns at Credit Suisse
As previously reported, Credit Suisse analyst Tim Ramskill downgraded Carnival (CCL) to Neutral from Outperform, as he is worried that his estimate of absolute industry capacity growth in 2018-2021 is double that of the last five years. This capacity growth is a greater concern given demand risks, said Ramskill, who cited risk to the top 3 cruise markets - the Caribbean post Hurricane Irma, the Mediterranean post the Barcelona terror attacks and China with the Korea travel ban still in place. He cut his 2018 yield growth view to 1.5% from 3%, lowered his EPS estimate by 10% and dropped his price target on Carnival shares to $70 from $78. Other publicly traded cruise operators include Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH).
09/15/17
FBCO
09/15/17
DOWNGRADE
Target $70
FBCO
Neutral
Carnival downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Tim Ramskill downgraded Carnival to Neutral and cut his price target for the shares to $70 from $78.
AAPL Apple
$150.55

-1.34 (-0.88%)

09/25/17
CHLM
09/25/17
NO CHANGE
CHLM
Initial Apple iPhone 8 likely weaker than previous iPhones, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss says that initial Apple (AAPL) iPhone 8/8 Plus sales are likely weaker than previous generation iPhone launches as consumers wait for the iPhone X set to go on sale for preorders October 27th and live in store's November 3rd. The analyst believes lack of carrier sweetheart deals like with the iPhone 7 launch have led to lower consumer demand, with Sprint (S) being the only carrier currently offering a free 64GB iPhone 8 with eligible trade-in of select devices. Stoss also thinks consumers waiting for the iPhone X is a "strong" positive for STMicroelectronics (STM) as he believes it likely has about $6-$8 in content in the iPhone X versus $3-$4 in the iPhone 8/8 Plus.
09/26/17
BFIN
09/26/17
NO CHANGE
BFIN
BlueFin says can't verify reports of poor iPhone pre-orders, component cuts
BlueFin analysts John Donovan and Steve Mullane said they have spent the past week tracking reports implying Apple's iPhone 8 pre-orders are tracking as much as 50% below the prior generation, both with an analyst in Asia as well as one in the Bay Area, and they cannot verify the severity of these claims. Additionally, they have "yet to uncover a single case" of a component company seeing its orders changed or reduced, the analysts tell investors. The analysts are still bullish on Apple and continue to think any near-term revenue shortfall due to iPhone X delays will be captured in the future quarters.
09/26/17
RAJA
09/26/17
NO CHANGE
Target $180
RAJA
Outperform
Apple iPhone X mix will be high but 'No Supercyle,' says Raymond James
Raymond James analyst Tavis McCourt said September survey results indicate no evidence of an accelerated upgrade cycle for the iPhone 8 or X, but suggests better demand for the X over the 8 due to the price difference and lack of "killer app." McCourt lowered his Apple iPhone FY18 unit outlook to 240M from 260M, but increased his gross margin and ASP assumptions based on new iPhone price points and mix, resulting in an increase in Apple's price target to $180 from $170. The analyst remains materially below consensus on December forecasts, and expects year-over-year growth to peak in first half 2018, which historically corresponded with stock peaks. McCourt views the recent pullback as a trading opportunity and maintains his Outperform rating.
09/25/17
KGIS
09/25/17
NO CHANGE
KGIS
Apple iPhone X preorder demand may top 40M-50M, says KGI Securities
KGI analyst Ming-Chi Kuo projects that preorder demand for the awaited iPhone X may have surpassed 40M-50M units. While the TrueDepth camera may be the main bottleneck of a ramp up in iPhone X production, he also thinks the camera's 3D sensing creates a far stronger user experience than those of rivals, he tells investors. Kuo notes investor concerns about shipments of iPhone X components, but he thinks some suppliers pulled in iPhone 8 to Q3 so that more resources can be allocated to the X in Q4.
AMZN Amazon.com
$939.79

-15.31 (-1.60%)

09/20/17
NRCS
09/20/17
NO CHANGE
NRCS
Henry Schein and Patterson concerns overdone, says Northcoast
Northcoast analyst Ed Snyder said Henry Schein (HSIC) and Patterson Companies (PDCO) have traded significantly lower in the past week due to concerns Amazon.com will increase exposure to the dental market. Snyder's research indicates Amazon is sourcing product from unsustainable sources including grey market sellers and privately-held Arnold Dental Supply, and not from large dental product manufacturers directly. He expects Arnold Dental to face increasing pressure from manufacturers who are annoyed product s are being sold via Amazon and notes many are not currently filling orders to replenish inventory. Further, Snyder said dentists value equipment service and support offered by traditional distributors far more than price discounts.
09/26/17
BARD
09/26/17
NO CHANGE
Target $24
BARD
Outperform
GameStop remains interesting, but speculative, value play, says Baird
Baird analyst Colin Sebastian hosted GameStop (GME) management and came away believing it remains an interesting, albeit speculative, value opportunity for investors. He said demand remains high for hardware but supplies remain tight. He also noted new software sales remain challenging given longer game lifecycles and the increasing digital download mix. Sebastian said the company is devoting more store space to collectibles, which is helping to drive store traffic. He also noted their PowerUp members have an overlap with Amazon (AMZN) Prime subscribers, which could make it a potential target of partnership interest. Sebastian reiterated his Outperform rating and $24 price target on GameStop shares.
09/26/17
WEDB
09/26/17
NO CHANGE
Target $60
WEDB
Outperform
Wedbush remains bullish on GrubHub despite Amazon competition
Wedbush analyst Aaron Turner maintains his long-term bullish view on shares of GrubHub (GRUB) and believes it is best positioned to benefit from the secular shift to digital in the restaurant take-out and delivery market. The analyst thinks Amazon (AMZN) is a "formidable opponent" for GrubHub and its recent partnership with Olo represents its continued commitment to the space. However, Turner believes the lack of wide-spread adoption of the Amazon restaurants platform by non-chains and the lack of prominence of the restaurants offering within its app continue to hamper diner adoption. Ultimately, he sees the market opportunity as large enough to support multiple businesses with GrubHub leading the way. The analyst reiterated an Outperform rating on GrubHub's shares, but lowered his price target on the stock to $60 from $63.
09/20/17
SBSH
09/20/17
NO CHANGE
Target $51
SBSH
Buy
Citi likes Kohl's swimming with the 'shark,' boosts target to $51
Citi analyst Paul Lejuez raised his price target for Kohl's (KSS) to $51 after the company announced its second partnership with Amazon (AMZN) this month. The collaboration, at a time when department stores are struggling, shows that Kohl's management is thinking out of the box, Lejuez tells investors in a research note. He believes the partnership can work to improve traffic. It is "better to be the 'pilot fish' that swims with the 'shark' than to be hunted by the shark," the analyst contends. He keeps a Buy rating on Kohl's.

TODAY'S FREE FLY STORIES

WILC

G. Willi-Food

$5.85

-0.14 (-2.34%)

18:35
10/19/17
10/19
18:35
10/19/17
18:35
Hot Stocks
G. Willi-Food receives notice from Arla Food ending distribution agreement »

G. Willi-Food's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$71.26

-0.46 (-0.64%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Macquarie Infrastructure CEO to become CEO of Macquarie Atlas Roads in 2018 »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

BIDU

Baidu

$264.52

-4.45 (-1.65%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Baidu collaborating with China's BAIC Group and King Long for autonomous driving »

Baidu signed strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

IBKC

Iberiabank

$80.15

0.05 (0.06%)

18:27
10/19/17
10/19
18:27
10/19/17
18:27
Hot Stocks
IBERIABANK to acquire Gibraltar Private Bank & Trust »

IBERIABANK Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

VBTX

Veritex

$27.04

-0.02 (-0.07%)

18:20
10/19/17
10/19
18:20
10/19/17
18:20
Hot Stocks
Veritex receives regulatory approval for Liberty Bancshares merger »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BHP

BHP Billiton

$41.56

0.06 (0.14%)

18:03
10/19/17
10/19
18:03
10/19/17
18:03
Hot Stocks
BHP Billiton CEO sees challenges around geopolitical uncertainty remaining »

In annual shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$1.97

0.03 (1.55%)

17:59
10/19/17
10/19
17:59
10/19/17
17:59
Hot Stocks
Durect: Phase 3 clinical trial for POSIMIR did not meet primary endpoint »

Durect reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.90

-0.1 (-5.00%)

17:49
10/19/17
10/19
17:49
10/19/17
17:49
Hot Stocks
Titan Pharmaceuticals presents non-clinical data from liothyronine implant »

Titan Pharmaceuticals is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$82.20

1.37 (1.69%)

17:46
10/19/17
10/19
17:46
10/19/17
17:46
Earnings
MSA Safety reports Q3 EPS 92c, consensus 80c »

Reports Q3 revenue $296M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

SKX

Skechers

$24.03

-1.06 (-4.22%)

, CAI

CAI International

$31.38

-0.05 (-0.16%)

17:41
10/19/17
10/19
17:41
10/19/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SKX

Skechers

$24.03

-1.06 (-4.22%)

CAI

CAI International

$31.38

-0.05 (-0.16%)

PYPL

PayPal

$67.25

-0.01 (-0.01%)

MXIM

Maxim Integrated

$50.09

0.24 (0.48%)

IMDZ

Immune Design

$5.50

-1.05 (-16.03%)

NCR

NCR Corp.

$37.05

-0.26 (-0.70%)

TACO

Del Taco

$15.39

-0.01 (-0.06%)

ATHN

athenahealth

$116.41

-4.37 (-3.62%)

ISRG

Intuitive Surgical

$357.46

3.09 (0.87%)

ETFC

E-Trade

$43.69

-0.23 (-0.52%)

CELG

Celgene

$135.96

-1.21 (-0.88%)

PBMD

Prima BioMed

$2.36

-0.02 (-0.84%)

AAXN

Axon

$24.62

-0.37 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 21

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 29

    Nov

DGX

Quest Diagnostics

$93.23

1.18 (1.28%)

17:37
10/19/17
10/19
17:37
10/19/17
17:37
Hot Stocks
Quest Diagnostics acquires Cleveland HeartLab, terms not disclosed »

Advantage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

AAXN

Axon

$24.62

-0.37 (-1.48%)

17:34
10/19/17
10/19
17:34
10/19/17
17:34
Hot Stocks
Axon says now aware of comment letter over SEC's review of 10-K, 10-Q »

Axon Enterprise said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on BioPharmX »

BioPharmX files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.74

0.0248 (3.47%)

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on MabVax Therapeutics »

MabVax Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$80.15

0.05 (0.06%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Earnings
Iberiabank reports Q3 non-GAAP EPS $1.00, consensus $1.16 »

Reports Q3 core revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

DRRX

Durect

$1.97

0.03 (1.55%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Hot Stocks
Breaking Hot Stocks news story on Durect »

Durect trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCP

Quality Care Properties

$16.26

0.07 (0.43%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Quality Care Properties provides update on HCR ManorCare »

Quality Care Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$11.48

0.02 (0.17%)

, CHH

Choice Hotels

$68.45

0.25 (0.37%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Frontier Communications named a Qualified Vendor with Choice Hotels Internationa »

Frontier Communications…

FTR

Frontier Communications

$11.48

0.02 (0.17%)

CHH

Choice Hotels

$68.45

0.25 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 08

    Nov

DRIO

DarioHealth

$1.98

-0.2 (-9.17%)

17:16
10/19/17
10/19
17:16
10/19/17
17:16
Syndicate
Breaking Syndicate news story on DarioHealth  »

DarioHealth files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBI

Customers Bancorp

$33.16

0.46 (1.41%)

17:11
10/19/17
10/19
17:11
10/19/17
17:11
Hot Stocks
Customers Bancorp to spin off BankMobile business »

Customers Bancorp plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 15

    Nov

MVC

MVC Capital

$10.40

0.08 (0.78%)

17:07
10/19/17
10/19
17:07
10/19/17
17:07
Hot Stocks
MVC Capital: Glass Lewis, Egan-Jones against proposal to cease new investments »

MVC Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CELG

Celgene

$135.96

-1.21 (-0.88%)

17:05
10/19/17
10/19
17:05
10/19/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Celgene »

Celgene down 6.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

NGD

New Gold

$3.57

0.03 (0.85%)

17:03
10/19/17
10/19
17:03
10/19/17
17:03
Hot Stocks
New Gold says Rainy River Mine achieves commercial production »

New Gold reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

COR

CoreSite Realty

$114.84

0.01 (0.01%)

17:02
10/19/17
10/19
17:02
10/19/17
17:02
Syndicate
Breaking Syndicate news story on CoreSite Realty »

CoreSite Realty files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 13

    Nov

SXT

Sensient

$78.26

-0.43 (-0.55%)

17:02
10/19/17
10/19
17:02
10/19/17
17:02
Earnings
Breaking Earnings news story on Sensient »

Sensient backs FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.